No Data
No Data
This week's Hong Kong stocks bull | Biotechnology stocks are strong, Recent IPOs company Yingen Biotechnology surged over 111% this week; gold prices continue to hit new highs! Chifeng Jilong Gold Mining skyrocketed nearly 37% during the week.
This week, the Hong Kong stock market showed a mixed trend, with technology stocks appearing somewhat sluggish. As of Thursday's market close, the Hang Seng Index increased by 2.3% for the week, closing at 21,395.14 points; the Hang Seng TECH Index fell by 0.27%, closing at 4,887.37 points.
The industry is hotly discussing the future trends of nuclear medicine, will Hybrid NewCo become a new model for the RDC Industry to venture abroad? | Industry Observation
① Today, the 2025 Future XDC New Drug Conference is held in Chengdu; ② Executives from companies such as Baillie Tianheng and Kelun Botai, along with numerous experts and scholars in the industry, will jointly discuss cutting-edge technologies in ADC/nuclear drug development, overseas strategies, and other Topics.
Zhongtai Securities: Multiple resonances from policy, industry, and technology will usher in the era of mass production of Siasun Robot&Automation in 2025.
Zhongtai released a Research Reports stating that in terms of policy, "embodied intelligence" has been included in the government work report for the first time, with a high level of importance placed on the strategic level.
The humanoid robot marathon will kick off on April 19, with the industry entering a phase of intensive catalysis.
① According to reports, the world's first humanoid robot half marathon will start at 7:30 AM on April 19th in Peking Yizhuang. ② Shanghai Securities pointed out that the Siasun Robot&Automation Industry Chain has entered a stage of "a hundred flowers blooming, a hundred schools of thought contending". Currently, humanoid robots are entering industrial scenarios, which has become a highly certain application trend domestically and globally. The commercialization of humanoid robots is promising, and attention is recommended for domestic component manufacturers that will benefit.
Everbright: Import substitution is expected to accelerate, pay attention to the rising market share of domestic surgical robots.
Everbright stated that the import substitution is expected to accelerate, paying attention to the rise in market share of domestic surgical robots.
China Merchants: Bullish on the trend of humanoid robot industry, suggest to focus on T-chain companies in the future.
China Merchants is Bullish on the trend of the humanoid robot industry and maintains a "Recommend" rating for the Sector.